British Society for Antimicrobial Chemotherapy

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 217.137.229.194 (talk) at 11:25, 27 June 2018 (→‎External links: Organisation). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

The British Society for Antimicrobial Chemotherapy (BSAC) is a UK-based multi-professional organisation with worldwide membership for clinicians and scientists with a specialist interest in antibiotic management and therapy. BSAC was founded in 1971 and is headquartered in Birmingham, UK.

Activities

Current BSAC activities include:

  • Publishes the Journal of Antimicrobial Chemotherapy.
  • Organises numerous annual educational sessions, workshops and small conferences for clinicians, researchers, clinical scientists and academics.
  • Development of national standardised tests to determine micro-organism susceptibility to antibiotics,[1]
  • Surveillance of resistance rates of organisms involved in the development of respiratory infections and bacteraemias.[2][3]
  • Out-patient parenteral antibiotic therapy (OPAT) Initiative. The OPAT Initiative is involved in the development of a body of evidence that include good practice recommendations, a business case toolkit and a patient management system to support clinicians in the provision of parenteral antibiotics away from the hospital in-patient setting.[4]
  • Advocates appropriate prescribing of antimicrobials including coordinating and submitting UK data on antimicrobial consumption to the European Centre for Disease Prevention and Control (ECDC).
  • Point Prevalence Survey (PPS) system and outcomes registry which enables UK hospital Trusts to report antibiotic point prevalence results and to compare and contrast their usage with other Trusts, regions and national administrations.[5]

References

  1. ^ Howe, R; Andrews, J. (2012), "BSAC standardized disc susceptibility testing method (version 11).", Journal of Antimicrobial Chemotherapy, 67 (12): 2783–2784, doi:10.1093/jac/dks391
  2. ^ Resistance Surveillance website
  3. ^ Reynolds, R.; Hope, R.; Williams, L. (2008), "Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes", Journal of Antimicrobial Chemotherapy, 62 (supplement 2): ii15–ii28, doi:10.1093/jac/dkn349
  4. ^ Out-Patient Antimicrobial Therapy website
  5. ^ Point Prevalence Survey website

External links